Nabil Fawzi is a seasoned professional with extensive experience in finance and management within the healthcare industry. Currently serving as a Senior Advisor and Deputy Group CEO at Pathology Asia since November 2018, Nabil also assumes multiple leadership roles including Director at North Borneo Capital Pte Ltd, Executive Director & CEO at Innoquest Pathology, and Board Member positions at several organizations such as Lablink Medical Laboratory, Singapore Diagnostics, and Safework Health. Nabil's educational background includes a Bachelor of Commerce in Finance & Accounting from The University of Western Australia and a Postgraduate Degree in Business Administration and Management from Manchester Business School.
Sign up to view 1 direct report
Get started
This person is not in any teams
This person is not in any offices